An observational study of the treatment of patients with mild and moderate COVID-19 (including suspected patients)

A multicenter, observational study of Western and Kampo medicine treatment for mild and moderate COVID-19 patients (including suspected patients) to alleviate symptoms and reduce severity of disease - An observational study on the treatment of patients with mild and moderate COVID-19

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041301

Enrollment

1000

Registered

2020-08-04

Start date

2020-07-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 patients(including suspected patients)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COVID-19 patients (including suspected patiets) Mild and moderate disease Over 20 years old Male and female Can communicate in Japanese Those who have been prescribed Western or Kampo medicines

Exclusion criteria

Exclusion criteria: Patients who have difficulty communicating and remembering due to dementia, psychosis or psychiatric symptoms Severe illness (requires oxygen administration) Other patients deemed unsuitable by the study physician

Design outcomes

Primary

Measure	Time frame
symptom relief and reduction of severity of the disease	—

Countries

Japan

Contacts

Public ContactAkiko Kuwabara

Tohoku University Hospital Department of Education and Support for Regional Medicine, Department of Kampo Medicine

akiko.kuwabara.d7@tohoku.ac.jp022-717-7507

Outcome results